| 논문 및 연구활동 |
- 연구활동(주요논문)
-
[논문]
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
(ONCOGENE)
- 2017.05
전상민, 정병진, 이선형, 장수환, 신은애, 김수열, 고현정, 최은지, 유환식
-
[논문]
Regulation and Function of AMPK in Physiology and Diseases
(EXPERIMENTAL AND MOLECULAR MEDICINE)
- 2016.07
전상민
-
[논문]
Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms
(CANCER CELL)
- 2016.04
전상민, Nissim Hay, Wang Qi, Xinyu Chen, Xiao-Ding Peng, Morris J. Birnbaum, Grace Guzman, Wan-Ni Yu
-
[논문]
The double-edged sword of AMPK signaling in cancer and its therapeutic implications
(ARCHIVES OF PHARMACAL RESEARCH)
- 2015.03
전상민, Nissim Hay
-
[논문]
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
(NATURE)
- 2012.05
전상민, Nissim Hay, Naveedip Chandel
- 국제학술논문지
-
[논문]
A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
(ONCOGENE)
- 2017.05
전상민, 정병진, 이선형, 장수환, 신은애, 김수열, 고현정, 최은지, 유환식
-
[논문]
Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells
(ONCOTARGET)
- 2017.04
전상민, 고현정, 진영원, 김진웅, 홍은혜, 이재영, 권보은, 송재형, 허은영, 장선영, 박예정
-
[논문]
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer
(SCIENTIFIC REPORTS)
- 2016.07
윤석준, 김나영, 임화영, He N, 이철중, 김주현, Mills G, 이혜숙, 김소민, 정유나, 송미, 김우영, 조용연, 전상민, 최진성
-
[논문]
Regulation and Function of AMPK in Physiology and Diseases
(EXPERIMENTAL AND MOLECULAR MEDICINE)
- 2016.07
전상민
-
[논문]
Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice
(PLoS ONE)
- 2016.05
고현정, 권보은, 송재형, 송혁환, 강주은, 조성찬, 이기종, 심애리, 홍은혜, 김연정, 장선영, 김동은, 전상민, 황삼노
-
[논문]
Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms
(CANCER CELL)
- 2016.04
전상민, Nissim Hay, Wang Qi, Xinyu Chen, Xiao-Ding Peng, Morris J. Birnbaum, Grace Guzman, Wan-Ni Yu
-
[논문]
The double-edged sword of AMPK signaling in cancer and its therapeutic implications
(ARCHIVES OF PHARMACAL RESEARCH)
- 2015.03
전상민, Nissim Hay
-
[논문]
The dark face of AMPK as an essential tumor promoter
(CELLULAR LOGISTICS)
- 2012.10
전상민, Nissim Hay
-
[논문]
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
(NATURE)
- 2012.05
전상민, Nissim Hay, Naveedip Chandel
-
[논문]
The effect of Akt2 deletion on tumor development in Pten+/- mice.
(ONCOGENE)
- 2012.01
Nissim Hay, Xu PZ, Peng XD, 전상민, Chen ML
-
[논문]
FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor
(DEVELOPMENTAL CELL)
- 2010.04
Nissim Hay, Chen CC, Park Y, Nogueira V, Sundararajan D, Tonic I, 전상민, Bhaskar PT
-
[논문]
mTORC1 Hyperactivity Inhibits Serum Deprivation-Induced Apoptosis via Increased Hexokinase II and GLUT1 Expression, Sustained Mcl-1 Expression, and Glycogen Synthase Kinase 3β Inhibition
(MOLECULAR AND CELLULAR BIOLOGY)
- 2009.09
Nissim Hay, Bhaskar PT, Robey RB, Patra KC, Park Y, 전상민, Nogueira V
-
[논문]
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice
(MOLECULAR AND CELLULAR BIOLOGY)
- 2009.06
Nissim Hay, Chen WS, Peng XD, Wang Y, Philipson LH, Chen ML, Luo Y, Coleman K, Haschek WM, Bass J, 전상민, Xu PZ
-
[논문]
A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts
(BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS)
- 2006.09
박주배, 최봉근, 배창대, 김은희, 성연선, 전상민, 홍경욱
-
[논문]
Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas
(JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY)
- 2003.11
박주배, 배창대, 성연선, 안경환, 양한관, 김영일, 박기호, 최종선, 전상민, 서유신
- 국제학술발표
-
[학술회의]
Accelerating precision cancer medicine by integrating cancer genomics with drug repositioning
(대한약학회 춘계국제학술대회)
- 2017.04
전상민
-
[학술회의]
A clinical drug library screen identifies clobetasol propionate as a potent NRF2 inhibitor and a promising repurposed therapeutic agent for lung cancers with high NRF2 activity
(대한약학회 70주년 국제학술대회)
- 2016.10
전상민, 정병진, 김수열, 유환식, 신은애, 최은지, 이선형
-
[학술회의]
Understanding metabolic adaptations for cancer therapy
(2016 Cancer Metabolism: Light in the Darkness)
- 2016.09
전상민
-
[학술회의]
Dual activation of AMPK and NRF2 during metabolic stress defines co-operating antioxidant defense mechanisms in cancer
(Keystone Symposia - Frontiers in Cancer Metabolism)
- 2016.02
전상민, Georgia Hatzivassiliou, 최은지
-
[학술회의]
Integrative Approaches to Develop Novel Therapeutic Strategies by Exploring the LKB1-AMPK Paradox in Lung Cancer
(2015 Bio Korea)
- 2015.04
전상민
-
[학술회의]
Therapeutic Implications and Business Development by Regulation of LKB1-AMPK Pathway in Cancer
(제 1차 한중 암대사 워크숍)
- 2014.12
전상민
-
[학술회의]
Metabolism and Cancer: Old Friends are the Best Friends
(2014 Spring International Convention of The Parmaceutical Society of korea)
- 2014.04
전상민
- 국내학술발표
-
[학술회의]
New insights into the mechanisms of metabolic adaptation in cancer
((사)대한약학회 신약개발네트워크분과 창립기념 심포지움)
- 2017.04
전상민
-
[학술회의]
AMPK and NRF2 cooperate to promote tumor cell survival during metabolic stress
(하이원 신약개발 심포지엄)
- 2017.01
전상민, 최은지, Georgia Hatzivassiliou, 유환식
-
[학술회의]
Co-occurring mutations in LKB1 and KEAP1 in lung cancer synergize tumor growth
(하이원 신약개발 심포지엄)
- 2017.01
전상민, Georgia Hatzivassiliou, 최은지
-
[학술회의]
Clobetasol propionate, a synthetic glucocorticoid, is a novel GSK3-dependent NRF2 inhibitor displaying promising therapeutic efficacy in KEAP1-mutant lung cancers
(하이원 신약개발 심포지엄)
- 2017.01
전상민, 김수열, 이선형, 최은지, 정병진
-
[학술회의]
Exploiting Metabolic Adaptations for Cancer Therapy
(한국유방암학회 중개연구회 심포지엄)
- 2016.11
전상민
-
[학술회의]
NRF2 조절을 통한 폐암 치료 신약개발
(신약개발분과회 추계 워크숍)
- 2016.10
전상민
-
[학술회의]
Dissecting the Role of AMPK in Cancer
(2016 대한신경종양학회 추계학술대회)
- 2016.09
전상민
-
[학술회의]
The LKB1-AMPK and KEAP1-NRF2 pathways synergize antioxidant defense during metabolic stress in cancer
(2016 cMIG 춘계 워크숍)
- 2016.03
전상민
-
[학술회의]
A clinical drug library screen identifies glucocorticoids as novel NRF2 inhibitors and promising repurposed therapeutics for lung cancers with high NRF2 activity.
(하이원신약개발심포지아)
- 2016.01
전상민, 최은지, 정병진
-
[학술회의]
High frequency of co-occurring mutations in LKB1 and KEAP1 in lung cancer confers combinatorial oncogenic driver pathway allowing concurrent activation of both mTORC1-mediated growth and NRF2-mediated antioxidant defense
(하이원신약개발심포지아)
- 2016.01
전상민, Georgia Hatzivassiliou, 최은지
-
[학술회의]
Dual activation of AMPK and NRF2 during metabolic stress is a critical fail-safe mechanism for metabolic adaptation in cancer
(제5차 암대사 워크숍)
- 2015.11
전상민
-
[학술회의]
Novel therapeutic opportunities behind the LKB1-AMPK paradox in lung cancer
(The 2nd KSBMB DDC JEJU WORKSHOP)
- 2015.07
전상민
-
[학술회의]
Business development by regulation of metabolic pathway in cancer and challenges for clinical application
(2015년 한국임상암학회 제 13차 정기 심포지움 및 총회)
- 2015.05
전상민
-
[학술회의]
Understanding the LKB1-AMPK pathway in cancer for novel therapeutic interventions
(2015년 생명 약학 연구회 동계 심포지엄)
- 2015.02
전상민
-
[학술회의]
Developing novel anti-cancer strategies integrating cancer genomics, signaling and metabolism network
(2014 Lee Gil Ya Cancer and Diabetes Institute Symposium)
- 2014.11
전상민
-
[학술회의]
Exploring the LKB1-AMPK paradox and Its Implications for Cancer Therapy
(제 38회 세포생물학회 하계 학술대회)
- 2014.07
전상민
-
[학술회의]
Exploring the LKB1 Paradox in Cancer: A Tumor Suppressor with a Key Role in Tumor Stress Adaptation and Its Therapeutic Implications
(동아 제 1차 항암 미니 심포지엄)
- 2014.04
전상민
-
[학술회의]
Exploring the LKB1 paradox: a tumor suppressor with a key role in tumor stress adaptation
(제5회 생화학분자생물학회 동계학술대회)
- 2014.01
전상민
-
[학술회의]
Exploring the LKB1-AMPK paradox: A tumor suppressor pathway with a key role in tumor stress adaptation
(제1회 아주대학교 의약학 공동 심포지움)
- 2013.09
전상민, Anneleen Daemen, Leisa Johnson, Georgia Hatzivassiliou, David Stokoe
- 저서 및 번역
|
교수진/연구실
